U.S. Stocks Move | Plans to Issue $2 Billion Convertible Senior Notes, Moderna (MRNA.US) Drops Over 5%

According to Zhihui Finance APP, on Thursday, Moderna (MRNA.US) opened lower and continued to decline. As of press time, it had fallen by more than 5%, with a market capitalization of approximately $56.6 billion. In terms of news, Moderna will issue $2 billion worth of convertible senior notes. Previously, Moderna and Merck jointly announced that the personalized cancer vaccine intismeran, developed in collaboration with Keytruda (pembrolizumab), achieved both core endpoints—recurrence-free survival (RFS) and distant metastasis-free survival (DMFS)—in the phase III INTerpath-001 trial targeting completely resected stage IIB to IV melanoma. Over the past week, the stock recorded an increase of nearly 130%.